ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare,…
- Recall date
- November 8, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0076-2025
- FDA classification
- Class II
- Brand / firm
- ACCORD HEALTHCARE, INC.
- Sold / distributed
- USA Nationwide
Why it was recalled
Subpotent drug
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-449-17
Get recall alerts
Free email alert whenever ACCORD HEALTHCARE, INC. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ACCORD HEALTHCARE, INC.